It seems as if nearly every biotech and pharmaceutical on the planet is hard at work developing new cancer drugs. That’s a good thing for cancer patients. And it’s good for dividend-seeking investors as well, since many of the companies in the cancer drug space pay nice dividends.
Three drugmakers in particular offer highly attractive dividends right now: AbbVie (NYSE: ABBV), AstraZeneca (NYSE: AZN), and Pfizer (NYSE: PFE). Here’s what makes these the top dividend stocks in cancer drugs.